ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 746

Childhood-Onset Takayasu’s Arteritis (TAK) Is Clinically More Active, However Has Similar Cumulative Damage Compared to Adult-Onset TAK

Murat Karabacak1, Sema Kaymaz-Tahra 2, Sezgin Sahin 3, Mehmet Yıldız 4, Amra Adrovic 5, Kenan Barut 6, Haner Direskeneli 7, Ozgur Kasapcopur 8 and Fatma Alibaz-Oner 1, 1Marmara University Faculty of Medicine,Department of Rheumatology,Istanbul,Turkey, Istanbul, Turkey, 2Marmara University School of Medicine, Division of Rheumatology, Istanbul, Istanbul, Turkey, 3Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey, Istanbul, Istanbul, Turkey, 4Department of Pediatric Rheumatology, Istanbul University Cerrahpasa, Istanbul, Istanbul, Turkey, 5Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey, Istanbul, Turkey, 6Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey, İstanbul, Istanbul, Turkey, 7Marmara University, School of Medicine, Division of Rheumatology, Istanbul, Turkey, 8Department of Pediatric Rheumatology, Istanbul University-Cerrahpasa, Istanbul, Turkey, Istanbul, Turkey

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: pediatrics and large vessel vasculitis, Takayasu arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Takayasu's Arteritis & Polymyalgia Rheumatica

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Childhood-onset Takayasu’s Arteritis (TAK) may differ in presentation, clinical manifestations and treatment, as previously shown1. We aimed to compare the clinical manifestations, vascular involvement patterns, activity, damage and treatments used in childhood- and adult-onset TAK patients.

Methods: Patients from two cohorts of TAK from two tertiary-care centers in Turkey were retrospectively studied. Patients of the adult clinic were also classified as childhood-onset if they were diagnosed before the age of 18. Clinical presentation, angiographic data and treatment regimens were reviewed from clinical charts. The activity was determined by Indian Takayasu Clinical Activity Score (ITAS) on the first visit. Takayasu Arteritis Damage Score (TADS) and Vasculitis Damage Index (VDI) were employed to document the damage.

Results: Twenty four childhood-onset and 121 adult-onset TAK patients were included in the analysis (Table 1). In the basal visits, claudication of the arms [74 (62.2%) vs. 5 (20.8%), p< 0.001], carotidynia [19 (16%) vs. 0, p= 0.043], subclavian bruit [63 (58%) vs. 8 (35%), p= 0.044] and the loss of radial pulse [63 (57.8%) vs. 8 (34.8%), p= 0.044] were more common in adult-onset patients. In contrast, ischemic abdominal pain [5 (21%) vs. 8 (7%), p= 0.07], renal [9 (39%) vs. 15 (14%), p= 0.014] and abdominal bruits [11 (48%) vs. 9 (8%), p< 0.001] were more common in childhood-onset patients. Angiographic distribution of the involved vessels is shown in Table 2. Median ITAS score on the first visit was 15 (IQR: 10) for pediatric-onset and 13 (IQR: 6) for adult-onset cases (p=0.57). Medical treatment and surgical/interventional modalities are shown in Table 3. Median TADS score was 8 (IQR: 8) and 8 (IQR: 4) for pediatric and adult cases, respectively (p=0.91). Median VDI of the pediatric cases were slightly lower [ 4 (IQR:3) vs. 5 (IQR:3), p: 0.037]. Four of the adult patients and none of the pediatric patients died during follow-up. At least one episode of remission was achieved in 12 (50%) of pediatric cases and 91 (75%) of adults (p=0.013). Among patients who had information regarding activity status, 12 (50%) of pediatric cases, and 88 (82%) of the adults were in remission at the last visit.

Conclusion: In childhood-onset TAK, the involvement of the aorta was more common, whereas the upper extremity was relatively spared as evidenced by symptoms and imaging. Remission was harder to achieve in pediatric cases, and they were treated with more biologic agents. Although more surgeries were also required, the cumulative damage seemed similar in both groups.

References

  1. Sahin, S. et al.  Childhood‐onset Takayasu arteritis: A 15‐year experience from a tertiary referral center. Int J Rheum Dis.  2019; 22: 132– 139.


Table 1

Table 1. Demographics, clinical characteristics and angiographic classification of childhood-onset and adult-onset TAK patients


Table 2

Table 2. Distribution of angiographic abnormalities -DSA, MRA or CTA-


Table 3

Table 3. Comparison of medical and surgical treatments in childhood- and adult-onset patients


Disclosure: M. Karabacak, None; S. Kaymaz-Tahra, None; S. Sahin, AbbVie, 2; M. Yıldız, None; A. Adrovic, AbbVie, 2; K. Barut, AbbVie, 2; H. Direskeneli, None; O. Kasapcopur, AbbVie, 2; F. Alibaz-Oner, None.

To cite this abstract in AMA style:

Karabacak M, Kaymaz-Tahra S, Sahin S, Yıldız M, Adrovic A, Barut K, Direskeneli H, Kasapcopur O, Alibaz-Oner F. Childhood-Onset Takayasu’s Arteritis (TAK) Is Clinically More Active, However Has Similar Cumulative Damage Compared to Adult-Onset TAK [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/childhood-onset-takayasus-arteritis-tak-is-clinically-more-active-however-has-similar-cumulative-damage-compared-to-adult-onset-tak/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/childhood-onset-takayasus-arteritis-tak-is-clinically-more-active-however-has-similar-cumulative-damage-compared-to-adult-onset-tak/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology